Segment, Customer and Geographical Reporting (Tables)

6 Months Ended

Mar. 31, 2013

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

The Company’s segment information for the three months ended March 31, 2013 and 2012 is summarized below:

Results of Operations for the Three Months Ended March 31,
2013
	Contract Research			Optics		Instruments			Biomedical			Total
Revenue	$	5,487,850		$	3,931,766	$	1,014,320		$	50,594		$	10,484,530
Gross Profit		2,647,870			1,632,007		461,101			50,594			4,791,572
Impairment of goodwill & long-lived assets		-0-			-0-		6,763,072			-0-			6,763,072
Operating Income (Loss)		232,015			2,336		(7,270,801	)		(211,564	)		(7,248,014	)
Depreciation and Amortization		79,637			184,696		164,384			15,000			443,717
Capital expenditures		(187,425	)		87,536		-0-			-0-			(99,889	)
Intangibles, Net		349,786			866,488		2,349,767			209,997			3,776,038
Goodwill		4,938,625			1,197,017		-0-			-0-			6,135,642
Total Assets		13,332,151			9,748,703		4,862,956			334,658			28,278,468

Results of Operations for the Three Months Ended March 31,
2012
	Contract Research		Optics		Instruments			Biomedical			Total
Revenue	$	6,978,973	$	3,684,213	$	1,629,248		$	6,576		$	12,299,010
Gross Profit		2,771,643		1,471,367		837,368			3,965			5,084,343
Operating Income (Loss)		158,278		30,970		(538,996	)		(249,968	)		(599,716	)
Depreciation and Amortization		57,777		155,597		134,699			15,000			363,073
Capital expenditures		85,199		183,965		12,823			-0-			281,987
Intangibles, Net		402,434		1,790		5,374,500			270,000			6,048,724
Goodwill		4,938,625		2,115,376		6,299,571			-0-			13,353,572
Total Assets		12,797,372		11,385,312		15,276,724			249,537			39,708,945

The Company’s segment information for the six months ended March 31, 2013 and 2012 is summarized below:

Results of Operations for the Six Months Ended March 31,
2013
	Contract Research			Optics		Instruments			Biomedical			Total
Revenue	$	10,398,690		$	8,183,706	$	2,298,358		$	157,051		$	21,037,805
Gross Profit		4,861,923			3,332,562		1,066,902			157,051			9,418,438
Impairment of goodwill & long-lived assets		-0-			-0-		6,763,072			-0-			6,763,072
Operating Income (Loss)		231,409			388,012		(7,726,495	)		(332,227	)		(7,439,301	)
Depreciation and Amortization		142,419			370,324		327,432			30,000			870,175
Capital expenditures		(1,095	)		209,682		7,092			-0-			215,679
Intangibles, Net		349,786			866,488		2,349,767			209,997			3,776,038
Goodwill		4,938,625			1,197,017		-0-			-0-			6,135,642
Total Assets		13,332,151			9,748,703		4,862,956			334,658			28,278,468

Results of Operations for the Six Months Ended March 31,
2012
	Contract Research		Optics		Instruments			Biomedical			Total
Revenue	$	13,204,256	$	7,596,764	$	3,612,784		$	17,501		$	24,431,305
Gross Profit		5,211,931		2,933,785		2,088,791			(23,216	)		10,211,291
Operating Income (Loss)		303,495		195,093		(459,452	)		(452,524	)		(413,388	)
Depreciation and Amortization		94,937		349,100		269,156			30,000			743,193
Capital expenditures		347,219		324,841		15,268			-0-			687,328
Intangibles, Net		402,434		1,790		5,374,500			270,000			6,048,724
Goodwill		4,938,625		2,115,376		6,299,571			-0-			13,353,572
Total Assets		12,797,372		11,385,312		15,276,724			249,537			39,708,945

Schedule Of Segment Revenue By Geographical Location [Table Text Block]

Revenue by geographic location in total and as a percentage of total revenue, for the three months ended March 31, 2013 and 2012 are as follows:

	Three Months Ended					Three Months Ended
	March 31, 2013					March 31, 2012
Geographic Location	Revenue		% of Total			Revenue		% of Total
United States	$	8,572,033		82	%	$	10,287,397		84	%
Europe		847,662		8	%		1,103,021		9	%
Other		1,064,836		10	%		908,592		7	%
	$	10,484,530		100	%	$	12,299,010		100	%

Revenue by geographic location in total and as a percentage of total revenue, for the six months ended March 31, 2013 and 2012 are as follows:

	Six Months Ended					Six Months Ended
	March 31, 2013					March 31, 2012
Geographic Location	Revenue		% of Total			Revenue		% of Total
United States	$	17,066,521		82	%	$	20,315,876		83	%
Europe		1,736,003		8	%		2,229,373		9	%
Other		2,235,282		10	%		1,886,056		8	%
	$	21,037,805		100	%	$	24,431,305		100	%